| Dysfunction of ventral striatal reward prediction in schizophrenia G Juckel, F Schlagenhauf, M Koslowski, T Wüstenberg, A Villringer, ... Neuroimage 29 (2), 409-416, 2006 | 692 | 2006 |
| Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics G Juckel, F Schlagenhauf, M Koslowski, D Filonov, T Wüstenberg, ... Psychopharmacology 187, 222-228, 2006 | 365 | 2006 |
| Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine F Schlagenhauf, G Juckel, M Koslowski, T Kahnt, B Knutson, T Dembler, ... Psychopharmacology 196, 673-684, 2008 | 248 | 2008 |
| Ventral striatal activation during reward processing in subjects with ultra-high risk for schizophrenia G Juckel, E Friedel, M Koslowski, H Witthaus, S Özgürdal, Y Gudlowski, ... Neuropsychobiology 66 (1), 50-56, 2012 | 92 | 2012 |
| Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia M Ballmaier, F Schlagenhauf, AW Toga, J Gallinat, M Koslowski, M Zoli, ... Schizophrenia research 106 (2-3), 140-147, 2008 | 89 | 2008 |
| Learning to let go: a cognitive-behavioral model of how psychedelic therapy promotes acceptance M Wolff, R Evens, LJ Mertens, M Koslowski, F Betzler, G Gründer, ... Frontiers in psychiatry, 5, 2020 | 80 | 2020 |
| Switching schizophrenia patients from typical neuroleptics to olanzapine: effects on BOLD response during attention and working memory F Schlagenhauf, T Wüstenberg, K Schmack, M Dinges, J Wrase, ... European Neuropsychopharmacology 18 (8), 589-599, 2008 | 59 | 2008 |
| Chorea in systemic lupus erythematosus JF Baizabal-Carvallo, M Alonso-Juarez, M Koslowski JCR: Journal of Clinical Rheumatology 17 (2), 69-72, 2011 | 57 | 2011 |
| Using routine MRI data of depressed patients to predict individual responses to electroconvulsive therapy M Gärtner, E Ghisu, AL Herrera-Melendez, M Koslowski, S Aust, P Asbach, ... Experimental neurology 335, 113505, 2021 | 8 | 2021 |
| Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE)–Rationale and study design LJ Mertens, M Koslowski, F Betzler, R Evens, M Gilles, A Jungaberle, ... Neuroscience Applied 1, 100104, 2022 | 4 | 2022 |
| Novel Treatment Approaches for Substance Use Disorders: Therapeutic Use of Psychedelics and the Role of Psychotherapy M Koslowski, MW Johnson, G Gründer, F Betzler Current Addiction Reports, 1-11, 2022 | 3 | 2022 |
| Cannabis use, use motives and cannabis use disorder among Berlin college students H Naegele, F Betzler, L Viohl, M Koslowski, F Ernst, MB Petzold Journal of Drug Issues 52 (4), 568-584, 2022 | 1 | 2022 |
| Ventral striatum activation by typical versus atypical neuroleptics in a fMRI paradigm with monetary incentive stimuli G Juckel, F Schlagenhauf, M Koslowski, D Filonow, B Knutson, J Wrase, ... Pharmacopsychiatry 38 (05), A109, 2005 | 1 | 2005 |
| OPEN ACCESS EDITED BY OH Turnbull, DF Mosri, SA Mota-Rolim, M Koslowski, M Koslowski, ... Frontiers in psychodynamic neuroscience, 231, 2023 | | 2023 |
| Converging Theories on Dreaming-between Freud, Predictive Processing and Psychedelic Research M Koslowski, MP De Haas, T Fischmann Frontiers in Human Neuroscience 17, 9, 2023 | | 2023 |
| P. 0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE)–study design, rationale and current status LJ Mertens, M Koslowski, F Betzler, R Evens, M Gilles, A Jungaberle, ... European Neuropsychopharmacology 53, S306, 2021 | | 2021 |
| LSD in der Therapie psychischer Erkrankungen M Koslowski InFo Neurologie+ Psychiatrie 22, 14-15, 2020 | | 2020 |
| Therapie mit Psychedelika - die Rolle der Psychotherapie M Koslowski, F Betzler, G Gründer, H Jungaberle, M Wolff NeuroTransmitter, 2020 | | 2020 |
| Der Einfluss typischer und atypischer Neuroleptika auf das dopaminerge Belohnungssystem bei Patienten mit Schizophrenie: eine fMRT-Studie M Koslowski | | 2009 |
| Number of operations of the reward system for schizophrenic patients with conventional anti psychotic and after changeover to olanzapine F Schlagenhauf, G Juckel, M Koslowski, T Kahnt, T Dembler, B Knutson, ... NERVENARZT 78, 77-77, 2007 | | 2007 |
Florian Schlagenhauf1Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, HumboldtBestätigte E-Mail-Adresse bei charite.de
